Role of EEG as a monitoring tool in patients with glucose transporter type I deficiency syndrome (GLUT1‐DS) on ketogenic diet

Abstract

AbstractRationaleGlucose transporter type I deficiency syndrome (GLUT1‐DS) is the fourth most frequent single‐gene epilepsy refractory to standard antiepileptic drugs. Multiple seizure types and variable electrographic findings are reported. Ketogenic diet is expected to result in the complete resolution of the epileptiform activity.MethodsA retrospective chart review of patients with GLUT1‐DS on ketogenic diet between December 2012 and February 2022 was done. Analysis of the EEGs prior to and during the ketogenic diet was done.Results34 patients on ketogenic diet were reviewed. Ten had clinical diagnosis of GLUT1‐DS, and seven of them had genetic confirmation. 71% were female. The average age at seizure onset was 13.85 m.o. (range: 3–60, SD ±20.52), at diagnosis was 44.57 m.o (range: 19–79), and at the onset of ketogenic diet was 46.43 m.o. (range: 20–83). 29 months (range: 13–38) delay between symptoms onset until diagnosis was noticed. At the diagnosis 100% reported seizures: 71% myoclonic, 57% generalized motor, 57% absence, 28% atonic, and 14% focal motor. Also, 71% abnormal eye movements, 57% ataxia, and 28% intolerance to fasting. 86% had normal brain MRI. 71% had abnormal EEG. All were on ketogenic diet, and four on classical (1.75:1–2.25:1 ratio). Six were clinically seizure‐free after the ketogenic diet. EEG features included notch delta, focal spike and wave, and generalized spike/polyspike and wave. One patient had bilateral independent centrotemporal spikes. Spikes showed high and very high amplitude in all of them (>200 μV). The variation of the spike index decreased in three patients but increased in two.ConclusionKetogenic diet is the choice treatment for patients with GLUT1‐DS. Electrographic features could show worsening after initiation of the ketogenic diet even with seizure control. EEG did not prove to be a reliable tool for adjusting KD in our cohort. Centrotemporal spikes have not been reported in patients with GLUT‐1 DS.